Daiwa Securities Group Inc. - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 15 filers reported holding CLOVIS ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q3 2022$0
-100.0%
4060.0%0.00%
Q2 2022$1,0000.0%4060.0%0.00%
Q1 2022$1,0000.0%4060.0%0.00%
Q4 2021$1,000
-50.0%
4060.0%0.00%
Q3 2021$2,000
+100.0%
406
+144.6%
0.00%
Q2 2021$1,0000.0%1660.0%0.00%
Q1 2021$1,0000.0%1660.0%0.00%
Q4 2020$1,0000.0%166
-50.6%
0.00%
Q3 2019$1,000
-80.0%
3360.0%0.00%
Q2 2019$5,000
-37.5%
3360.0%0.00%
Q1 2019$8,000
+60.0%
336
+24.0%
0.00%
Q4 2018$5,000
-37.5%
2710.0%0.00%
Q3 2018$8,000
-33.3%
2710.0%0.00%
Q2 2018$12,000
-14.3%
2710.0%0.00%
Q1 2018$14,0002710.00%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q4 2022
NameSharesValueWeighting ↓
Coppell Advisory Solutions LLC 229$11,0080.00%
View complete list of CLOVIS ONCOLOGY INC shareholders